TUMOR-NECROSIS-FACTOR AS EFFECTOR MOLECULE IN MONOCYTE MEDIATED CYTOTOXICITY

Google Scholar
  • 1 November 1986
    • journal article
    • research article
    • Vol. 46  (11) , 5947-5952
Abstract
A newly developed assay system which uses actinomycin D (Act D) pretreated Wehi 164 target cells allows for the measurement of human monocyte cytotoxicity in a 7-h 51Cr release assay. Using the monocyte specific monoclonal antibody M42 in a direct rosetting procedure we confirm herein that among human peripheral blood mononuclear cells cytotoxicity is restricted to monocytes. When applying stringent conditions that exclude exogenous lipopolysaccharide (LPS) we could demonstrate that as litle as 0.1 ng of LPS per ml triggers this cytotoxicity. Further, a factor can be detected in supernatants of mononuclear cells which is also cytotoxic against Act D treated Wehi 164 cells. This cytotoxic factor can be triggered by LPS within 4 h, but at as low a LPS concentration as 0.001 ng/ml. Since one of the LPS triggered monocyte products is tumor necrosis factor (TNF), we tested the effect of recombinant TNF cloned from the U937 cell line and one could show potent lytic activity against Act D pretreated but not, or only minimally, against untreated Wehi 164 target cells. Recombinant TNF rapidly lysed the target with significant specific release occurring as early as after 3 h in the assay. By contrast, recombinant interleukin 1 gave no lysis while lymphotoxin derived from the RPMI 1788 cell line was effective. An affinity purified antiserum directed against TNF neutralized the lytic activity of recombinant TNF and also the cytotoxic factor produced by LPS triggered mononuclear cells, while the antiserum was ineffective against lymphotoxin. Further, the antiserum when added to the assay of effector cells and Act D treated Wehi 164 cells also completely ablated cytotoxic activity. Size fractionation of cytotoxic factor and recombinant TNF by high pressure liquid chromatography led to a superimposable peak of cytotoxicity in the molecular weight range of 9,500-17,000. Further, immunoblotting with the anti-TNF antibody revealed the same Mr, 15,500-16,500 band for the recombinant TNF and LPS triggered cytotoxic factor. Taken together, our data demonstrate that the cytotoxic activity of human monocytes against Act D treated Wehi 164 is mediated entirely by a LPS triggered molecule that is very similar or identical to the human tumor necrosis factor. The assay system thus provides a powerful tool to analyze the biology of TNF in humans.